Notably, in our study, we showed for the first time that the inverse association between plasma adiponectin levels and the presence/severity of NAFLD remained statistically significant even after adjusting for the PNPLA3 rs738409 variant or other less common NAFLD-related genetic polymorphisms. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.